Holen Sie sich die Stockscreener-App
7.00
5.15%
-0.38
Handel nachbörslich:
7.00
Schlusskurs vom Vortag:
$7.38
Offen:
$7.39
24-Stunden-Volumen:
117.92K
Relative Volume:
0.63
Marktkapitalisierung:
$86.69M
Einnahmen:
$3.57M
Nettoeinkommen (Verlust:
$-7.80M
KGV:
-7.2143
EPS:
-0.9703
Netto-Cashflow:
$-6.56M
1W Leistung:
-3.45%
1M Leistung:
-10.94%
6M Leistung:
+162.17%
1J Leistung:
+131.02%
1-Tages-Spanne:
$6.95
$7.49
1-Wochen-Bereich:
$6.95
$7.60
52-Wochen-Spanne:
$2.1963
$9.33
Neuraxis Inc Stock (NRXS) Company Profile
Firmenname
Neuraxis Inc
Sektor
Branche
Telefon
(812) 689-0791
Adresse
11550 North Meridian Street, Suite 325, Carmel
Compare NRXS vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NRXS
Neuraxis Inc
|
7.00 | 91.40M | 3.57M | -7.80M | -6.56M | -0.9703 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Neuraxis Inc Aktie (NRXS) Neueste Nachrichten
Neuraxis Inc. (NRXS) Holds Near Support After Marginal DeclineMA Cross Alert - Newser
Neuraxis Inc. (NRXS) Q1 2026 Earnings: Narrower Loss Beats Estimates, but Stock Slips on Pre‑Revenue Concerns - Newser
NeurAxis Earnings Call Highlights Growth and Hurdles - TipRanks
Minot Light Capital Fund Drops 2.7 Percent Amid Sector Rotation - HarianBasis.co
NeurAxis (NRXS) Climbs on Reimbursement and Guideline Momentum - Insider Monkey
Neuraxis (NRXS) Stock Analysis: -5.84% Loss — Key Levels 2026-05-18Stock Idea Hub - Newser
NeurAxis slides 21%, raises $5M via stock - MSN
The surprise hidden in Neuraxis NRXS last earnings report Q4 2025 Earnings Beat EstimatesCrowd Verified Signals - Newser
NeurAxis Stock Gains Post Q1 Earnings, Revenues and Margin Surge Y/Y - Yahoo Finance
NeurAxis revenues up 80% to USD 1.6M in Q1 2026 - Medical Buyer
Craig-Hallum Sticks to Its Buy Rating for NeurAxis, Inc. (NRXS) - The Globe and Mail
TradingKey - TradingKey
NeurAxis signals burn rate of $1M or less for rest of 2026 while targeting ~ $15M revenue for cash flow breakeven - MSN
Neuraxis Inc (NRXS) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid Coverage Challenges - Investing.com Canada
Earnings call transcript: Neuraxis Q1 2026 sees record revenue growth - Investing.com
Neuraxis Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
NRXS: Q1 2026 revenue up 80% year-over-year, with margin and adoption gains in covered markets - TradingView
NeurAxis, Inc. Reports 80% Revenue Growth in Q1 2026 Driven by CPT Code Assignment and Expanded Product Adoption - Quiver Quantitative
Neuraxis, INC 1Q 2026: Revenue $1.61M, EPS $(0.18) — 10-Q Summary - TradingView
NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth - GlobeNewswire
NeurAxis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
The surprise hidden in Neuraxis (NRXS) last earnings report | Q4 2025: Earnings Beat EstimatesCommunity Risk Signals - newser.com
Neuraxis | ARS: Annual Report to Security Holders - Moomoo
NeurAxis (NRXS) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
What the smart money sees in Neuraxis (NRXS) that retail does not (Near Lows) 2026-05-08Open Stock Picks - newser.com
Number of shareholders of Neuraxis, Inc. – AMEX:NRXS - TradingView
NRXS Neuraxis Q4 loss narrows more than expected, but shares dip 0.11% despite EPS beat.CFO Commentary - newser.com
The critical factors shaping Neuraxis (NRXS) future (Technical Weakness) 2026-05-08Retail Trader Ideas - newser.com
This Small-Cap Healthcare Stock Is Up 300% in a Year and Is Quickly Gaining a Following - inkl
NeurAxis will post first-quarter results before market open May 12 - Stock Titan
NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026 - GlobeNewswire
The Zacks Analyst Blog Highlights Alphabet, Walmart, Micron Technology and NeurAxis - Yahoo Finance
Top stock reports for Alphabet, Walmart & Micron - MSN
Bigger Capital, Michael Bigger report NRXS holdings (NRXS) and warrant limits - Stock Titan
Neuraxis | SCHEDULE 13G/A: Others - Moomoo
Neuraxis (NRXS) director Gil reports stock awards from Series B dividend - Stock Titan
Neuraxis | 4: Statement of changes in beneficial ownership of securities-Director Aharon Gil - Moomoo
NeurAxis (NRXS) price target increased by 29.41% to 11.22 - MSN
NRXS Ownership | NEURAXIS INC (NYSEARCA:NRXS) - ChartMill
Neuraxis (NRXS) asks investors to expand 2022 stock plan and approve ESPP - Stock Titan
Neuraxis | DEF 14A: Definitive information statements - Moomoo
NeurAxis (NRXS) price target increased by 21.43% to 8.67 - MSN
NeurAxis (NASDAQ:NRXS) Trading Up 5.5%Here's What Happened - MarketBeat
NRXS Should I Buy - Intellectia AI
NeurAxis Expands At-The-Market Equity Offering Capacity - The Globe and Mail
Neuraxis increases at-the-market offering capacity to $11.5 million on NYSE American - Investing.com India
Neuraxis increases ATM capacity to $11.5M after $6.27M program sales - TradingView
Neuraxis (NRXS) boosts at-the-market share sale capacity to $11.5M - Stock Titan
Neuraxis, Inc. Files Form 8-K Current Report with SEC – Company Details, Address, and Trading Information (April 21, 2026) 345726 - Minichart
NeurAxis Inc (NYSEARCA:NRXS) Shows Strong Technical and Fundamental Momentum - ChartMill
1.25 million more people gain access to NeurAxis' IBS pain device - Stock Titan
Finanzdaten der Neuraxis Inc-Aktie (NRXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
0.12%
Kapitalisierung:
|
Volumen (24h):